ALC-315 Trademark

Trademark Overview


On Tuesday, March 19, 2024, a trademark application was filed for ALC-315 with the United States Patent and Trademark Office. The USPTO has given the ALC-315 trademark a serial number of 98456478. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, September 27, 2024. This trademark is owned by Acuitas Therapeutics, Inc.. The ALC-315 trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics as pharmaceutical preparations; pharmaceutical preparations comprised of lipid nanoparticles for treating and preventing a wide variety of diseases and conditions

Lipids for scientific purposes, research and development purposes, and research laboratory use; lipid nanoparticles for scientific purposes, research and development purposes, and research laboratory use; lipid formulations for scientific purposes, research and development purposes, and research laboratory use; compositions including lipids and nucleic acids, including messenger RNA, for scientific purposes, research and development purposes, and research laboratory use
alc-315

General Information


Serial Number98456478
Word MarkALC-315
Filing DateTuesday, March 19, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, September 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkALC THREE FIFTEEN
Pseudo MarkALC THREE HUNDRED FIFTEEN
Goods and ServicesPharmaceutical preparations, namely, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics as pharmaceutical preparations; pharmaceutical preparations comprised of lipid nanoparticles for treating and preventing a wide variety of diseases and conditions
Pseudo MarkALC THREE ONE FIVE
Goods and ServicesLipids for scientific purposes, research and development purposes, and research laboratory use; lipid nanoparticles for scientific purposes, research and development purposes, and research laboratory use; lipid formulations for scientific purposes, research and development purposes, and research laboratory use; compositions including lipids and nucleic acids, including messenger RNA, for scientific purposes, research and development purposes, and research laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcuitas Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, B.C. V6T1W5
CA

Trademark Events


Event DateEvent Description
Tuesday, March 19, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2024ASSIGNED TO EXAMINER
Friday, September 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 27, 2024NON-FINAL ACTION E-MAILED
Friday, September 27, 2024NON-FINAL ACTION WRITTEN